Mean platelet volume is a predictive and prognostic marker for patients with acute myeloid leukemia: a two-center retrospective analysis

References

• PDQ Pediatric Treatment Editorial Board. Childhood acute lymphoblastic leukemia treatment (PDQ®), in PDQ Cancer Information Summaries. Bethesda (MD): National Cancer Institute (US); 2019
   Google Scholar
• Yamamoto JF, Goodman MT. Patterns of leukemia incidence in the United States by subtype and demographic characteristics, 1997-2002. Cancer Causes Control. 2008;19(4):379–390.
   PubMed Web of Science ®Google Scholar
• Patel JP, Gönen M, Figueroa ME, et al. Prognostic relevance of integrated genetic profiling in acute myeloid leukemia. N Engl J Med. 2012;366(12):1079–1089.
   PubMed Web of Science ®Google Scholar
• Liersch R, Müller-Tidow C, Berdel WE, et al. Prognostic factors for acute myeloid leukaemia in adults-biological significance and clinical use. Br J Haematol. 2014;165(1):17–38.
   PubMed Web of Science ®Google Scholar
• Yildiz A, Maral S, Albayrak M, et al. Are the conventional risk factors still valid for acute myeloid leukemia patients? Konuralp Med J. 2020;12(1):5–11.
   Google Scholar
• Chen C-C, Yang C-F, Yang M-H, et al. Pretreatment prognostic factors and treatment outcome in elderly patients with de novo acute myeloid leukemia. Ann Oncol. 2005;16(8):1366–1373.
   PubMed Web of Science ®Google Scholar
• Keating MJ, Smith TL, Gehan EA, et al. Factors related to length of complete remission in adult acute leukemia. Cancer. 1980;45(8):2017–2029.
   PubMed Web of Science ®Google Scholar
• Sikora J, Kostka B. Blood platelets as pharmacological model. Post Biol Kom. 2005;232:561–570.
   Google Scholar
• Peterson B, Bloomfield C. Prolonged maintained remissions of adult acute non-lymphocytic leukaemia. The Lancet. 1977;310(8030):158–160.
   Google Scholar
• Coltman CA, Bodey GP, Hewlett JS, et al. Chemotherapy of acute leukemia: a comparison of vincristine, cytarabine, and prednisone alone and in combination with cyclophosphamide or daunorubicin. Arch Intern Med. 1978;138(9):1342–1348.
   PubMedGoogle Scholar
• Etienne A, Esterni B, Charbonnier A, et al. Comorbidity is an independent predictor of complete remission in elderly patients receiving induction chemotherapy for acute myeloid leukemia. Cancer. 2007;109(7):1376–1383.
   PubMed Web of Science ®Google Scholar
• Juliusson G, Antunovic P, Derolf A, et al. Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry. Blood. 2009;113(18):4179–4187.
   PubMed Web of Science ®Google Scholar
• Wahlin A, Markevärn B, Golovleva I, et al. Prognostic significance of risk group stratification in elderly patients with acute myeloid leukaemia. Br J Haematol. 2001;115(1):25–33.
   PubMed Web of Science ®Google Scholar
• Arlin Z, Feldman EJ, Finger L, et al. “Quality” remissions: a new target of induction therapy in acute leukemia and the next step in developing curative treatment. Semin Hematol. 1991;28(4):44–47.
   PubMedGoogle Scholar
• Tucker J, Thomas AE, Gregory WM, et al. Acute myeloid leukemia in elderly adults. Hematol Oncol. 1990;8(1):13–21.
   PubMed Web of Science ®Google Scholar
• Ntaios G, Papadopoulos A, Chatzinikolaou A, et al. Increased values of mean platelet volume and platelet size deviation width may provide a safe positive diagnosis of idiopathic thrombocytopenic purpura. Acta Haematol. 2008;119(3):173–177.
   PubMed Web of Science ®Google Scholar
• Qian X, Wen-Jun L. Platelet changes in acute leukemia. Cell Biochem Biophys. 2013;67(3):1473–1479.
   PubMed Web of Science ®Google Scholar
• Santos FdJ, Figueira DdO, Souza JEdO. Prevalence of discordant microscopic changes with automated CBC analysis. J Brasileiro Patol Med Lab. 2014;50(6):398–401.
   Google Scholar
• Jackson S, Carter J. Platelet volume: laboratory measurement and clinical application. Blood Rev. 1993;7(2):104–113.
   PubMed Web of Science ®Google Scholar
• Bessman JD, Williams LJ, Gilmer PR. Jr, Platelet size in health and hematologic disease. Am J Clin Pathol. 1982;78(2):150–153.
   PubMed Web of Science ®Google Scholar
• Alsweedan SA, Al-Shurman A, Mahmoud A-S. Diagnostic value of platelet indices in children with leukemia. J Pediatr Hematol/Oncol. 2008;30(12):953–955.
   PubMed Web of Science ®Google Scholar
• Gondo K, Miyachi H, Kawada T, et al. Estimation of megakaryothrombopoiesis by mean platelet volume in leukemia patients during the course of chemotherapy and patients undergoing bone marrow transplantation. Rinsho Ketsueki. 1993;34(7):835–841.
   PubMedGoogle Scholar
• Merdin A, Dal MS, Çakar MK, et al. Analysis of pre-chemotherapy WBC, PLT, monocyte, hemoglobin, and MPV levels in acute myeloid leukemia patients with WT1, FLT3, or NPM gene mutations. Medicine. 2020;99(14):e19627.
   PubMed Web of Science ®Google Scholar
• Huang Z, Liu WJ, Guo QL, et al. Platelet parameters and expression of platelet membrane glycoprotein in childhood acute lymphoblastic leukemia. Genet Mol Res. 2015;14(4):16074–16089.
   PubMed Web of Science ®Google Scholar
• Kim MJ, Park P-W, Seo Y-H, et al. Comparison of platelet parameters in thrombocytopenic patients associated with acute myeloid leukemia and primary immune thrombocytopenia. Blood Coagul Fibrinol. 2014;25(3):221–225.
   PubMed Web of Science ®Google Scholar
• Brown AS, Hong Y, de Belder A, et al. Megakaryocyte ploidy and platelet changes in human diabetes and atherosclerosis. ATVB. 1997;17(4):802–807.
   Google Scholar
• Endler G, Klimesch A, Sunder-Plassmann H, et al. Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease. Br J Haematol. 2002;117(2):399–404.
   PubMed Web of Science ®Google Scholar
• Gasparyan AY, Ayvazyan L, Mikhailidis DP, et al. Mean platelet volume: a link between thrombosis and inflammation? Curr Pharm Des. 2011;17(1):47–58.
   PubMed Web of Science ®Google Scholar
• Van Etten RA. Aberrant cytokine signaling in leukemia. Oncogene. 2007;26(47):6738–6749.
   PubMed Web of Science ®Google Scholar
• Sanchez-Correa B, Bergua JM, Campos C, et al. Cytokine profiles in acute myeloid leukemia patients at diagnosis: survival is inversely correlated with IL-6 and directly correlated with IL-10 levels. Cytokine. 2013;61(3):885–891.
   PubMed Web of Science ®Google Scholar